Omnicare Exec Faces Medicaid Fraud Charges
This article was originally published in The Pink Sheet Daily
The company itself is not being investigated, but is setting aside litigation reserves.
You may also be interested in...
AmerisourceBergen and Kindred Healthcare announce plans to combine institutional pharmacy businesses into a new publicly traded company.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.